APP and Alzheimer disease: Finally, Dai et al. used APPswe/PS1E9 (APP/PS1) transgenic mice, a well-established AD model [11], to investigate the effects of subchronically injected fullerene C60 suspension (460 μg/kg, i.p.)and found significant effects of the treatment on memory acquisition in the Morris water maze [7].